Physicians’ Education Resource® Educates on Cutting-Edge Cancer Breakthroughs & Treatments at the 38th Annual Chemotherapy...
02 November 2020 - 6:53PM
Business Wire
Three-day virtual conference features over 100
internationally renowned faculty discussing latest clinical
insights and data for the future of cancer care.
Physicians’ Education Resource® LLC (PER®) proudly announces
that its historic 38th Annual Chemotherapy Foundation Symposium
(CFS®): Innovative Cancer Therapy for Tomorrow® will be held
Nov. 4-6 and has transformed into an all-inclusive, three-day
continuing medical education (CME)-certified, virtual, interactive
experience that focuses on the state of cancer treatment today and
innovative cancer breakthroughs that impact patient care strategies
tomorrow.
Each year, the Chemotherapy Foundation Symposium® (CFS®) brings
together more than 2,000 healthcare professionals for three days
with the aim of promoting the delivery of evidence-based,
state-of-the-art cancer care for both routine and the most
challenging clinical scenarios. The legacy meeting will be hosted
through an interactive platform that provides attendees with
virtual networking opportunities throughout the robust agenda
covering a broad spectrum of oncology specialties.
“The 38th Annual CFS®, is one of our largest and most
influential oncology conferences of the year,” said Phil Talamo,
president of PER®. “We are excited more than ever this year to
provide our attendees with a VIP virtual experience and premiere
access to network with the top minds in oncology. Join us in
November for an impactful meeting and learn about innovative new
approaches to optimize care and outcomes for patients.”
Returning co-chairs Benjamin P. Levy, M.D., and
William K. Oh, M.D., are joined by Tiffany A. Traina,
M.D., associate attending physician, clinical director of
breast medicine service, vice chair of oncology care in the
department of medicine and section head of the Triple Negative
Breast Cancer Clinical Research Program at Memorial Sloan Kettering
Cancer Center, to chair the conference and provide an unparalleled
CME experience.
At the 38th Annual CFS® virtual conference, internationally
renowned thought leaders will cover over 25 tumor types, providing
participants with expert insights on the latest developments in
cancer therapeutics, offering an unparalleled opportunity to learn
how innovative approaches fit into existing treatment paradigms to
optimize care and outcomes for their patients with cancer.
Attendees can also submit questions and participate in expert
discussions real time via PER®’s custom interactive platform. To
view the full agenda, click here.
Accredited by the Accreditation Council for Continuing Medical
Education and the Accreditation Council for Pharmacy Education, and
approved by the California Board of Registered Nursing, this live
activity will provide participants with the opportunity to earn
24.25 AMA PRA Category 1 Credits™, 21.75 contact hours and 24.25
nursing contact hours.
For more information and to register, click here.
About Physicians’ Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care
through professional education and now advances patient care and
treatment strategies on a wide variety of chronic illnesses and
diseases. In 2016, PER® initiated continuing medical education
(CME) programming in the cardiovascular and endocrinology areas.
While expanding into topics outside oncology, PER® stands as the
leading provider of live, online and print CME activities related
to oncology and hematology. The high-quality, evidence-based
activities feature leading distinguished experts who focus on the
application of practice-changing advances. PER® is accredited by
the Accreditation Council for Continuing Medical Education and the
California Board of Registered Nursing. PER® is a brand of MJH Life
Sciences™, the largest privately held, independent, full-service
medical media company in North America dedicated to delivering
trusted health care news across multiple channels.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201102005825/en/
PER® Media Contact Alexandra Ventura, 609-716-7777
aventura@mjhlifesciences.com